spinning acid-cleaned glass slide through the hole in the center of the transparent cover. The spin coater was operated at a fixed spinning speed of 5400 rpm for 30 s. Details and photos of the spin coater can be found in Figure S1 .
S3. NanoLC Gradient
The gradient used for leupeptin and aprotinin started at 2% B for 6 min and then linearly increased to 60% B in 20 min and then to 90% B in the next 5 min. After an additional 3 min elution at 90% B, the column was reequilibrated at starting conditions (2% B) for 7 min. The total analysis time was 35 min. For the analysis of a mixture of leupeptin diastereoisomers (25 µM leupeptin) and snake venom samples the gradient was from 1% B to 60% B in 36 min and then in 2 min to 90% B, where it stayed isocratic for 2 min. At 44.1 min, mobile phase B decreased to 1% (starting conditions) and continued at this concentration until 60 min. The nanoLC system was controlled by Chromeleon version 6.80 SR12 software. For MS analysis, the samples were rerun using the same gradient. For MS analysis, leupeptin diastereoisomers were separated at a leupeptin concentration of 2 µM.
S4. Preparation of a Capillary Used for Effluent Picofractionation
For the picofractionation, ~30 cm of a fused-silica capillary of 75 µm I.D. and 365 µm O.D. was used of which the blunt tip was coated on the outside with MTMOS. Prior to coating with MTMOS solution, one end of the capillary was closed -by melting it with a burner -to prevent blocking the inside of the capillary with MTMOS solution during the coating process. The heating of the capillary was also done to remove the polyamide coating (3-4 cm of the tip). Coating with MTMOS solution (silylation) of the capillary tip was performed by immersing ~4 cm of the capillary (at this point closed) tip into MTMOS coating solution for ~5 min, after which the capillary was dried at ambient atmosphere (O/N placed in a fume-hood). The MTMOS coated tip was opened with the use of a capillary cutter in a straight line prior to use.
S5. Image Acquisition and Processing of The Microarray Data
Fluorescence intensities of the microarray bioassay droplets were measured kinetically by taking 24-bit images of 1200 pixels x 1200 pixels (width and height, respectively) separately for each bioassay droplet during incubation (i.e. developing microarray bioassay droplets). The time to acquire images of a complete microarray bioassay containing up to 300 single bioassay reactions was 7.5 min. In µManager, the Lumascope LED C, Channel C was selected with LED C illumination set to 160, camera gain set to 15, and camera image mode at RGB32. The multi-dimensional acquisition (MDA) option available in µManager enabled acquisition at multiple stage positions, in a serpentine fashion to follow the picofractionation pattern. The camera exposure time was set at 300 ms. Kinetic measurements were performed by taking 18 images of every single bioassay droplet reaction in intervals of 7.5 min. Captured images were saved as separate image files for further processing.
Fluorescence intensity for images with single spots at all intervals was calculated with the following equation 1 : Net Total Fluorescence Intensity = Integrated Density -(area of an image × fluorescence intensity of the background mean), using ImageJ 2 . In the equation, the Integrated Density of an image is the intensity of an entire image (containing the background and the fluorescence spot over an area of 1200 pixels x 1200 pixels). The mean fluorescence background intensity -for a complete microarray bioassay experiment -was measured using 20 randomly picked images acquired during the first interval of the measurement. In each of the 20 images, an area outside of the droplet was selected and the background intensity was extrapolated to get the background for a 1200 x 1200 pixel area. In order to automate processing of the acquired images and construct bioactivity chromatograms, an in-house written macro was implemented in ImageJ. Subsequently, a script written in R 3 was used to generate a kinetic curve for each microarray bioassay spot from each time interval measured using the calculated net total fluorescence intensity. The same R script was used to calculate slopes from the kinetic curves for each bioassay droplet reaction, which were finally plotted against their picofractionation time to create microarray bioactivity chromatograms (MBCs). The macro used for processing the data to obtain the MBCs can be found in Supporting Information S12.
S6. Performance of The Plasmin Microarray Bioassay
The performance of the microarray bioassay was first evaluated by determining IC50 values of the two plasmin inhibitors leupeptin and aprotinin. Leupeptin was analyzed at ten different concentrations ranging from 0-400 µM, and aprotinin at nine different concentrations ranging from 0-30 µM. The inhibitors were serially diluted in MilliQ water. To mimic nanoLC solvent delivery while still maintaining a continuous flow of the inhibitor solutions, nanoliter spots of the inhibitors were collected on MTMOS coated glass slides with the help of a syringe pump model 22 from Harvard Apparatus (Holliston, MA, USA). The inhibitors were delivered via a fused-silica capillary connected to a 250 µL volume Hamilton glass syringe (Supleco, Bellefonte, PA, USA) mounted on the syringe pump. Droplets of 100-nL formed at the tip of the capillary were dislodged/detached using 100 nL droplets ejected every 4 s with solenoid valve 1. Each inhibitor concentration to be bioassayed was spotted 5 times on two different glass slides. Next, the dried spots were exposed to the plasmin microarray bioassay following the same procedure as described earlier in the text.
S7. Quality of the plasmin microarray bioassay
In order to calculate the Z'-factor of the microarray bioassay, positive control samples (n=100) of 200 µM leupeptin (ensuring total enzyme inhibition) and negative control samples (n=100) consisting of mobile phase A were spotted in the same manner as described for the IC50 determination. Subsequent bioassay and data processing was done following the same procedure as described in the experimental section to obtain the kinetic slopes of each microarray reaction droplet data point. Using these kinetic slopes, the Z'-factor was calculated according to Zhang et al. 4 .
S8. Bioassay Droplets In Oil -Evaporation Observation
A mixture of enzyme and substrate (final concentration of enzyme was 200 ng/mL and substrate 5 µM) were deposited in a non-contact manner onto an MTMOS-coated glass slide, and directly covered by mineral oil droplet. The droplets were deposited in triplicate. 30 minutes after deposition (incubation in normal assay protocol) the droplets were monitored every 1.5 hours for 12 hours.
The results ( Figure S8 ) show that the mineral oil droplet shape and size is not affected in time. A slight change is observed (only between the first two measurements) in the (watery) bioassay droplet mixture inside the oil. This is most likely due to the hydrophobicity of the coating on the glass slide. It is thought that, rather than droplet evaporation, the change in shape occurs due to the upward push in order to decrease its surface area contact on the hydrophobic coated glass slide. Effectively, a slight rearrangement in the oil, which appears as a decrease in droplet size. We are not able to accurately monitor the possible change in height of the droplet in oil with the current setup to confirm this.
S9. Nanofractionation of Venoms and The Standards
The bioassay in 384 well plates for the analysis of the serial dilution of leupeptin and aprotinin and analysis of crude snake venoms was performed using a Shimadzu high-performance liquid chromatography (HPLC) system ('s Hertogenbosch, The Netherlands) consisting of a Shimadzu SIL-30 AC autosampler and two Shimadzu LC-30AB pumps, which were interfaced to an Bruker MAXIS Q-TOF MS instrument (Bruker, Bremen, Germany). The snake venoms B. asper, D. acutus, T.
trigonocephalus and T. purpureomaculatus were injected in a concentration of 1 mg/mL and 4 mg/mL (injected volume, 45 μL). Leupeptin and aprotinin standards (injected volume, 20 μL) were analyzed at five different concentrations (ranging from 10 to 100 μM and 0.077 μM to 30 μM, respectively). A 150 × 4.6 mm ID analytical column packed with XbridgeTM BEH300 reversed-phase C18 material (5 µm) was used for separations and was maintained at 37°C in a Shimadzu CTD-30A column oven.
Gradient elution was performed employing mobile phase A (98% water, 2% ACN, 0.1% FA (v/v/v)) and mobile phase B (98% ACN, 2% water, 0.1% FA (v/v/v)). The gradient used for separation started at 0% B with a linear increase to 50% B in 20 min followed by an increase to 90% B in 2 min. The gradient was held at 90% B for 2 min, and then returned in 1 min to the starting conditions (0% B).
Column reequilibration was 5 min, resulting in a total analysis time of 30 min. The flow rate was 0.5 mL/min. The column eluate was split in a 1:9 ratio using a low-dead-volume flow splitter. The For comparison of the performance of the picofractionation analytics with nanofractionation analytics, the same four venoms were nanofractionated at concentrations of 1 mg/mL and 4 mg/mL (data of the 1 mg/ml venoms are not shown as for none of these analyses, any positive or negative bioassay signal was observed) under the same conditions as described by Zietek et al. 5 In Figure S9 , it is shown that only Bothrops asper showed bioactivity signals at a concentration of 4 mg/mL, and the results obtained were similar to the picofractionation results. All the other snakes showed no visible activity ( Figure S10 ). Although, in the results obtained using the picofractionation platform the other three venoms, i.e. Deinagkistrodon acutus, Trimeresurus trigonocephalus and Trimeresurus purpureomaculatus showed bioactivity signals in a concentration of 1 mg/mL ( Figure 5 and Figure   S6 ), it has to be noted that the bioactive signals for these analyses were low. Due to sample preconcentration on the nanoLC column after injection, the eluting sample components in picofractionation analytics are much higher than for nanofractionation. Therefore, its apparent sensitivity for these analyses is higher and as such only for picofractionation for all four snakes analyzed bioactivity signals were observed (for the highest possible concentration injected of 4 mg/mL). For nanofractionation, the detection limit was thus not sufficient to successfully analyze Deinagkistrodon acutus, Trimeresurus trigonocephalus and Trimeresurus purpureomaculatus for bioactivity.
In addition, also for comparison and method validation, we now analyzed the standards leupeptin and aprotinin at the same concentrations as tested for the picofractionation analytics using the nanofractionation analytics. For the standards, merging broad peaks were observed for the picofractionation analytics when injected at high concentration (due to the preconcentration of the analytes on the nanoLC column), which separated into individual sharper peaks upon injecting more diluted samples. As a consequence, lower concentrations of the standards leupeptin and aprotinin can still be observed for picofractionation as compared to nanofractionation (see Figure S11 and S12 for the results obtained by nanofractionation analytics). This clearly shows the increased sensitivity of picofractionation as compared to nanofractionation analytics and it shows that picofractionation does not give lower resolution than nanofractionation analytics, but gives overlapping peaks due to bioassay saturation upon high concentrations injected, which separate into individual baseline separated sharp peaks upon injecting more diluted samples. As a consequence, much lower concentrations of the standards leupeptin and aprotinin can still be observed for picofractionation as compared to nanofractionation (see Figure S11 and S12, and Figure 3 ).
S11. Picofractionation Frequency Comparison
In this research we aimed at collecting 50 nL fractions of the nanoLC effluent, which is exactly 1000 times less than in our previous research. This resulted in 10-s fractions. Fractionation frequency can have an impact on the resolution of the microarray bioactivity chromatograms. However, it will not
give any improvement in our study as the chromatographic peaks of the venom toxins in our separations have much larger peak widths than the 10-s regime. The effective fraction volume when collecting 6-s fractions (as done for our nanofractionation analytics study by Zietek et al.
5
) is 30 nL.
Due to the hydrophobic coating on the end of the effluent capillary, this 30 nL effluent visibly protrudes out far enough to be effectively deposited on the glass slide by contactless deposition. We have compared the difference in bioassay readout when collecting 6s fractions and 10 s fractions. For this, five spots were picofractionated onto the glass slide with both fractionation velocities. Four of these spots were exposed to the plasmin assay, for both fractionation velocities ( Figure S13 ). As can be seen in this figure, both fractionation velocities, show very similar bioactivity curves.
In addition, these figures also demonstrate how bioactivity is screened in our picofractionation platform. Effectively, each spot on the glass slide is photographed 18 times. An increase in fluorescent readout is observed in time with positive bioassay performance. This fluorescent intensity can be determined, and with that a curve can be plotted. The slope of all these kinetic curves is used for reconstructed bioassay chromatograms. Further details of this are described in SI sections S5 and S12.
S12. An in-house written macro was implemented in ImageJ for automatic measurement of Integrated * some functionality needed by this script. * * roiWidth, roiHeight. default: 800, 800 
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// Clear previous results run("Clear Results"); showMessage("<html><h1><font color=red>No images found</font></h1><font color=blue>" + imageDirectory + "</font><html>"); For image capturing a digital camera containing a high sensitivity monochrome CMOS sensor was used; for focusing 3) an infinity corrected microscope objective (4x magnification; numerical aperture (NA) 0.13, working distance (WD) 17.2 mm, type number MA1012 from Meiji Techno) was placed in the objective holder of the Lumascope (the camera objective is changeable in Lumascope). asper venom correlated to UV at 220 nm. The reanalysis of the venom was performed with a nanofractionation system. 6-s fractions of the venom (injected concentration 4 mg/mL) were collected on a 384 microtiter well plate, and after drying, exposed to a plasmin bioassay. Bottom: Data obtained from the measurements of B. asper with the picofractionation system (results provided as Figure  5 in the main document). MBC = microarray bioassay chromatogram; RFU/min = relative fluorescence unit/min. Figure S10 . Bioassay chromatograms of D. acutus, T. trigonocephalus and T. purpureomaculatus correlated to UV at 220 nm. The reanalysis of the venoms was performed with a nanofractionation system. 6-s fractions of the venoms (injected concentration 4 mg/mL) were collected on a 384 microtiter well plate, and after drying, exposed to a plasmin bioassay. Detailed information on the measurement and description of the obtained data can be found in the Supporting Information section S10. RFU/min = relative fluorescence unit/min. Figure S11 . Superimposed bioactivity chromatograms resulting from bioassays of nanofractionated leupeptin standards injected at different concentrations on normal-bore LC-UV. All bioactivity chromatograms were normalized. The bioactivity chromatograms are correlated with the LC-UV trace (bottom) obtained from measurement of leupeptin at 100 µM. The data show that the nanofractionation and picofractionation platforms provide comparable results. RFU/min = relative fluorescence unit/min. Note that the separation efficiency between the leupeptin serial dilution in nanofractionation and picofractionation is not similar as a fast 30 minute gradient was used for the picofractionation serial dilution experiments ( Figure 3 in the manuscript). For better comparison of resolution and sensitivity, a picofractionation analysis of leupeptin at 25 µM concentration using the long 60 minute gradient is depicted on the right side of the figure. These results show an increased sensitivity of the picofractionation compared to nanofractionation, while maintaining the same resolution (i.e. baseline separation) as for leupeptin in the nanofractionation. With the 60 minute gradient (right side of this figure and Figure 4 in the main document), peaks were separated in a similar fashion as for nanofractionation. Figure S12 . Superimposed bioactivity chromatograms resulting from bioassays of nanofractionated aprotinin standards injected at different concentrations on normal-bore LC-UV. The bioactivity data have been normalized. The bioactivity chromatograms are correlated with LC-UV traces (bottom) obtained from measurement of aprotinin at 30 µM. The data show that the nanofractionation and picofractionation platforms provide comparable results. RFU/min = relative fluorescence unit/min.
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